At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion ... manufacture bulk substance for J&J’s ill-fated COVID-19 vaccine. The opening comes as U.S. biopharma companies ...

Merck & Co.'s first trial over the safety of its blockbuster cancer vaccine Gardasil was postponed mid-trial due to concerns that jurors might be influenced by media coverage surrounding the ...

Moderna is working with Merck to develop a cancer vaccine. Moderna also recently inked a supply deal for its Covid vaccine, Spikevax, in Europe. But Moderna missed its mark in a study of its ...

Novavax also earned global approvals for and commercialized its first vaccine ever for COVID-19 ... She previously served as President, Merck Vaccines and Infectious Disease, and after 26 years at ...

2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine ...

By Manas Mishra and Michael Erman (Reuters) -Merck ... COVID-19 hospitalizations and deaths. They could also become important tools in countries and areas with limited access to vaccines or ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.